Cargando…

Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience

BACKGROUND: The COVID-19 pandemic remains a pressing concern to patients with cancer as countries enter the second peak of the pandemic and beyond. It remains unclear whether cancer and its treatment contribute an independent risk for mortality in COVID-19. METHODS: We included patients at a London...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sng, Christopher C. T., Wong, Yien Ning Sophia, Wu, Anjui, Ottaviani, Diego, Chopra, Neha, Galazi, Myria, Benafif, Sarah, Soosaipillai, Gehan, Roylance, Rebecca, Lee, Alvin J. X., Shaw, Heather
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714940/ https://www.ncbi.nlm.nih.gov/pubmed/33330085 http://dx.doi.org/10.3389/fonc.2020.595804

Ejemplares similares

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital
por: Wong, Yien Ning Sophia, et al.
Publicado: (2021)

1734P Do cancer patients really do worse? A study in a UK tertiary hospital within a COVID-19 epicentre
por: Sng, C.C.T., et al.
Publicado: (2020)

1575P Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at University College London Hospital
por: Sinclair, A., et al.
Publicado: (2021)

1704P COVID-19 mortality in patients receiving anti-cancer therapy in a UK national cancer centre
por: Wu, A., et al.
Publicado: (2020)

Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
por: Soosaipillai, Gehan, et al.
Publicado: (2021)

1671MO Provision of palliative care for patients with cancer and SARS-CoV-2 infection
por: Soosaipillai, G.B., et al.
Publicado: (2020)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2015)

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
por: Pinato, David J., et al.
Publicado: (2020)

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
por: Pinato, David J., et al.
Publicado: (2021)

Breaking Bad News Training in the COVID-19 Era and Beyond
por: Soosaipillai, Gehan, et al.
Publicado: (2020)

An update on PARP inhibitors for the treatment of cancer
por: Benafif, Sarah, et al.
Publicado: (2015)

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
por: Trujillo, Blanca, et al.
Publicado: (2022)

Views of advance care planning in older hospitalized patients following an emergency admission: A qualitative study
por: Bielinska, Anna-Maria, et al.
Publicado: (2022)

The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
por: Davies, Caitlin R., et al.
Publicado: (2023)

Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance
por: Birts, Charles N., et al.
Publicado: (2010)

Incidence of Cancer in Sarcoidosis Patients in a Tertiary Care Hospital in the UK
por: Mannan, Sonia, et al.
Publicado: (2022)

HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models
por: Gómez, Valentí, et al.
Publicado: (2022)

Views of advance care planning in caregivers of older hospitalised patients following an emergency admission: A qualitative study
por: Bielinska, Anna-Maria, et al.
Publicado: (2020)

Frontline Maintenance Treatment for Ovarian Cancer
por: Elyashiv, Osnat, et al.
Publicado: (2021)

Assessing awareness of long-term health risks among women with a history of preeclampsia: a cross-sectional study
por: Mpalatsouka, Ismini, et al.
Publicado: (2023)

The Landscape of Adoptive Cellular Therapies in Ovarian Cancer
por: Davis, Lucy, et al.
Publicado: (2023)

Intravitreal injections: past trends and future projections within a UK tertiary hospital
por: Chopra, Reena, et al.
Publicado: (2021)

Radioiodine treatment of differentiated thyroid cancer despite history of ‘iodine allergy’
por: Puchalski, Adam R, et al.
Publicado: (2014)

A history of liaison psychiatry in the UK
por: Aitken, Peter, et al.
Publicado: (2016)

An oral history of health psychology in the UK
por: Quinn, Francis, et al.
Publicado: (2020)

The history of surgery and surgical training in the UK
por: Payne, Thomas, et al.
Publicado: (2021)

Reconstructing the history of helminth prevalence in the UK
por: Ryan, Hannah, et al.
Publicado: (2022)

Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole–body magnetic resonance imaging in radio-recurrent prostate cancer
por: Adeleke, Sola, et al.
Publicado: (2019)

Expert UK consensus on the definition of high risk of recurrence in HER2-negative early breast cancer: A modified Delphi panel
por: Copson, E.R., et al.
Publicado: (2023)

Systematic Review of Molecular Biomarkers Predictive of Resistance to CDK4/6 Inhibition in Metastatic Breast Cancer
por: Asghar, Uzma S., et al.
Publicado: (2022)

Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer
por: Krell, Daniel, et al.
Publicado: (2017)

Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel
por: Leongamornlert, Daniel A., et al.
Publicado: (2019)

The impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study
por: Taylor, R, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on prevalence of Clostridioides difficile infection in a UK tertiary centre
por: Voona, Sanjana, et al.
Publicado: (2022)

Risk-reducing surgery for individuals with cancer-predisposing germline pathogenic variants and no personal cancer history: a review of current UK guidelines
por: McCarthy, Rebecca L., et al.
Publicado: (2023)

Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
por: Giganti, Francesco, et al.
Publicado: (2020)

Clinical trials in cancer research.
por: Gehan, E A
Publicado: (1979)

Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development
por: Barber, Paul R, et al.
Publicado: (2022)

INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer
por: Johnston, Edward, et al.
Publicado: (2016)

Kallikrein gene downregulation in breast cancer
por: Yousef, G M, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_cak43cqolgj487nnpitv92lmar